Trading
Please use a PC Browser to access Register-Tadawul
Citigroup Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $35
Share
Catalyst Pharmaceuticals, Inc.
CPRX
23.23
-0.68%